Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Walgreens (WBA) Q2 Earnings: What To Expect

June 24, 2025 at 23:00 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

WBA Cover Image

Pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will be announcing earnings results this Thursday before market open. Here’s what to look for.

Walgreens beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $38.59 billion, up 4.1% year on year. It was a stunning quarter for the company, with an impressive beat of analysts’ EBITDA estimates and a solid beat of analysts’ same-store sales estimates.

Is Walgreens a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Walgreens’s revenue to be flat year on year at $36.59 billion, slowing from the 2.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.34 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Walgreens has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.5% on average.

Looking at Walgreens’s peers in the consumer retail segment, some have already reported their Q2 results, giving us a hint as to what we can expect. CarMax delivered year-on-year revenue growth of 6.1%, meeting analysts’ expectations, and Costco reported revenues up 8%, in line with consensus estimates. CarMax traded up 4.5% following the results while Costco was also up 3.1%.

Read our full analysis of CarMax’s results here and Costco’s results here.

Investors in the consumer retail segment have had fairly steady hands going into earnings, with share prices down 1.5% on average over the last month. Walgreens is up 1.6% during the same time and is heading into earnings with an average analyst price target of $12.41 (compared to the current share price of $11.39).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article